P. Luque-Navarro

Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell Lines

E. Parisini, L. C. López-Cara, A. Sola-Leyva, 2022, Pharmaceutics.

A solvatofluorochromic silicon-substituted xanthene dye useful in bioimaging

R. Salto, M. Girón, J. M. Paredes, 2019, Dyes and Pigments.

Anticancer Activity and Structure Activity Relationship of Non-Symmetrical Choline Kinase Inhibitors

G. Viola, L. C. López-Cara, C. Marco, 2021 .

New bioisosteric sulphur-containing choline kinase inhibitors with a tracked mode of action.

L. Goracci, E. Parisini, G. Viola, 2023, European journal of medicinal chemistry.

New Compounds with Bioisosteric Replacement of Classic Choline Kinase Inhibitors Show Potent Antiplasmodial Activity

E. Parisini, L. C. López-Cara, D. González-Pacanowska, 2021, Pharmaceutics.

Biological Evaluation of New Thienopyridinium and Thienopyrimidinium Derivatives as Human Choline Kinase Inhibitors

E. Parisini, G. Viola, L. C. López-Cara, 2022, Pharmaceutics.

Anticancer and Structure Activity Relationship of Non-Symmetrical Choline Kinase Inhibitors

G. Viola, L. C. López-Cara, C. Marco, 2021, Pharmaceutics.